USE OF A PEPTIDE DERIVED FROM THE BETA-SUBUNIT OF HCG IN ORDER TO GENERATE AN ANTITUMOUR CTL-TYPE RESPONSE

Details for Australian Patent Application No. 2003255563 (hide)

Owner PIERRE FABRE MEDICAMENT

Inventors GOETSCH, Liliane; AUBRY, JeanPierre; KLINGUER-HAMOUR, Christine; CORVAIA, Nathalie; BECK, Alain

Pub. Number AU-A-2003255563

PCT Number PCT/FR03/01420

PCT Pub. Number WO2003/095486

Priority 02/05691 07.05.02 FR

Filing date 7 May 2003

Wipo publication date 11 November 2003

International Classifications

C07K 014/59 Peptides having more than 20 amino acids

A61P 035/00 Antineoplastic agents

A61K 039/385 Medicinal preparations containing antigens or antibodies - Haptens or antigens, bound to carriers

Event Publications

6 November 2003 Complete Application Filed

  Priority application(s): 02/05691 07.05.02 FR

15 January 2004 Application Open to Public Inspection

  Published as AU-A-2003255563

12 May 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003255564-CLEANABLE DEVICE FOR DEPOLLUTION OF AN ENGINE EXHAUST GASES

2003255562-Method and system of representing a sound field